Černý, Vladimir
Maegele, Marc
Agostini, Vanessa
Fries, Dietmar
Leal-Noval, Santiago R.
Nardai, Gábor
Nardi, Giuseppe
Östlund, Anders
Schöchl, Herbert
Article History
Received: 26 May 2020
Accepted: 19 November 2020
First Online: 5 January 2021
Compliance with ethical standards
:
: All authors participated in the aforementioned advisory board, which was organised by CSL Behring. Gábor Nardai and Anders Östlund report no other conflicts of interest. Vladimir Černý has received speakers’ fees from CSL Behring. Marc Maegele has received lecture honoraria, fees for participating in expert and advisory panels, and financial funding for participating in conferences and undertaking scientific projects from Abbott Laboratories, Astra Zeneca, Bayer, Biotest, CSL Behring, IL-Werfen/TEM-International, LFB Biomedicaments France and Portola. Vanessa Agostini has received an honorarium for advisory board participation from Werfen. Dietmar Fries has received study funding, as well as honoraria for consultancy and board activity from Astra Zeneca, AOP orphan, Baxter, Baer, B. Braun, Biotest, CSL Behring, Delta Select, Dae Behring, Edwards, Fresenius, Glaxo, Haemoscope, Hemogem, Lilly, LFB, Mitsubishi Pharma, NovoNordisk, Octapharma, Pfizer, and Tem-Innovation. Santiago R Leal-Noval has received honoraria from CSL Behring for both conferences and meetings. Giuseppe Nardi is a member of the ABC-T European Medical Education Initiative Faculty, has received honoraria and travel funding for ABC-T meetings, and honoraria for lecturing for CSL Behring. Herbert Schöchl has received honoraria for participation in advisory board meetings from Bayer Healthcare, Böhringer Ingelheim, Werfen, speakers’ fees from Haemonetics and Vifor, and study grants from CSL Behring.